menu
    • menu

    Company profile for GW Pharmaceutical

    NEW Drugs in Dev: 3
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GW has established a world leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise. GW has developed an oral formulation of purified cannabidiol (CBD), approved as Epidiolex® in the U.S. by the U.S. Food and Drug Administration (FDA) for seizures associated with Lennox-G...
    GW has established a world leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise. GW has developed an oral formulation of purified cannabidiol (CBD), approved as Epidiolex® in the U.S. by the U.S. Food and Drug Administration (FDA) for seizures associated with Lennox-Gastaut syndrome or Dravet Syndrome, two rare and severe early-onset, drug-resistant epilepsy syndromes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GW Pharmaceuticalunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Sovereign House, Vision Park, Chivers Way, Histon, Cambridge, England, CB24 9B...
    Telephone
    Telephone
    +44 0 1980 557000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gwpharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jazz plots massive growth for UK cannabinoid operations
    Jazz plots massive growth for UK cannabinoid operations

    29 Mar 2022

    // J. Sullivan ENDPTS

    https://endpts.com/jazz-plots-massive-growth-for-uk-cannabinoid-operations/

    J. Sullivan ENDPTS
    29 Mar 2022
    Share Share
    Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
    Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing

    24 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-significant-new-investment-in-uk-manufacturing-301510400.html

    PRNEWSWIRE
    24 Mar 2022
    Share Share
    GW Pharma gets nod for reimbursement of Epidyolex
    GW Pharma gets nod for reimbursement of Epidyolex

    17 Dec 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=144689&sid=2

    PHARMABIZ
    17 Dec 2021
    Share Share
    Cannabidiol gains MHRA approval as adjunctive treatment of seizures
    Cannabidiol gains MHRA approval as adjunctive treatment of seizures

    11 Aug 2021

    // PHARMA FILE

    http://www.pharmafile.com/news/585060/cannabidiol-gains-mhra-approval-adjunctive-treatment-seizures

    PHARMA FILE
    11 Aug 2021
    Share Share
    GW Pharma Sells for Billions; Psychedelic Company Following Similar Path
    GW Pharma Sells for Billions; Psychedelic Company Following Similar Path

    29 Jun 2021

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gw-pharma-sells-for-billions-psychedelic-company-following-similar-path-301321752.html

    PR NEWSWIRE
    29 Jun 2021
    Share Share
    GW Pharma Sells for Billions; Psychedelic Company Following Similar Path
    GW Pharma Sells for Billions; Psychedelic Company Following Similar Path

    29 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gw-pharma-sells-for-billions-psychedelic-company-following-similar-path-301321752.html

    PRNEWSWIRE
    29 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Contact GW Pharmaceutical and get a quotation

    GW Pharmaceutical is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of Cannabidiol bulk offered by GW Pharmaceutical

    Find a price of Cannabis bulk offered by GW Pharmaceutical

    Find a price of Trimethadione bulk offered by GW Pharmaceutical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search